Niyogi describes herself as an experienced pharmaceutical market research professional who has time and again shown the ability to translate collected information into actionable insights. Her areas of expertise include qualitative and quantitative research and advanced analytics.
Niyogi has been serving as customer analytics and insights director for more than 11 years. In the role, she oversees strategic and cross-functional initiatives in the rare disease, inflammation and immunology, vaccines and hospital anti-infective businesses of Pfizer.
Her role also involves spearheading activities such as forecasting, competitive intelligence gathering and primary and secondary research, according to her LinkedIn profile.
Before joining Pfizer, she spent seven years at AstraZeneca Pharmaceuticals, which has also developed a COVID-19 vaccine.
At the Cambridge, England-headquartered pharmaceutical company, Niyogi worked as senior manager of market research.
During her time at AstraZeneca, Niyogi led the launch performance tracking of the company’s Nexium and Crestor products. She also spearheaded other forecasting initiatives and model development activities.
The Pfizer director is a graduate of Pennsylvania State University with a master’s degree in marketing and finance. Niyogi also holds a doctorate degree in statistics from the University of Maryland.